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The Human Genome Project and Minority Communities - Ethical,
Social, and Political Dilemmas (Raymond A. Zilinskas & Peter J.
Balint eds., Praeger Publishers 2001). Preface, index, about the
contributors. LC 00-032390; ISBN 0-275-96961-4 [160 pp. $54.50.
Cloth, 88 Post Road West, Westport, CT 06881].
This short, well-edited, collection of essays reflects and grew out of
the proceedings of the conference, "The Human Genome Project:
Reaching the Minority Communities in Maryland," held at the
University of Maryland in the summer of 1997. The editors' stated
objectives include: (1) building bridges between human genetics
researchers and the minority community in Maryland; (2) presenting an
introduction to the Human Genome Project (hereinafter HGP); and
(3) airing legal, ethical and social concerns the authors believe are raised
by the information produced through human genetics research. In
Chapter 11, the editors elaborate on their agenda in their own
contribution to the collection, "The HGP and Minority Communities:
The Importance of Dialogue and Access to Information." 1 This
provocative collection is for social scholars and students, and in
particular, community leaders involved with minority and public health
issues.
The editors argue that the distrust, skepticism and misconceptions
of minorities relating to genetics research must be overcome. Yet, the
editors report that the participants left the conference more
apprehensive than when they came. Scientifically unsophisticated
readers of the book will fare no better. Reference, often without dates,
is five times made to the Tuskegee syphilis experiment of forty years
ago. Negative reference is made innumerable times to misuse of genetic
information, discredited twin studies, eugenics, and to Hernstein and
First editor Raymond A. Zilinskas, Ph.D, is a Senior Scientist at the Center for
I
Nonproliferation Studies, Monterey Institute of International Studies in Monterey, CA, where
he studies effective biological arms control. He is editor of Biological Warfare: Modern
Offense and Defense (Lynne Rienner Publishers, 1999). His doctoral dissertation at the
University of Southern California addressed policy and ethical issues generated by DNA
research. Co-editor Peter J. Balint is an Adjunct Lecturer in Quantitative Methods at the
University of Maryland, where he is a Ph.D. candidate in environmental policy at the School of
Public Affairs.
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Murray's controversial 1994 book The Bell Curve. Indeed, the index
lists nine separate entries for The Bell Curve. While the editors can
perhaps be forgiven for ignoring, in a collection aimed at social
scientists, the solid research supportive of biological determinism and
the benevolent uses of genetic information, the treatment comes off
one-sided.
To their credit, however, the editors and contributors acknowledge
that the HGP is conducted in accordance with the highest ethical
standards, and has the potential to make dramatic positive
contributions to the health of all human beings. Several contributors
explore the notion that members of minority communities in particular
who statistically are at high risk -- have much to gain from
innovative medical diagnostics and therapies that will result from the
study of human genetics.
The editors also report failure in their goal of interesting the
government and private foundations in involving minority communities
at the state-level in redistributing the benefits of genetic research and
the HGP, to ensure that those benefits are "shared equitably." The
editors do not adequately elaborate on this intriguing thesis. They do,
however, express a generalized fear that the benefits of the HGP will
disproportionately accrue to the privileged and a generalized concern
that the information produced will be beneficial primarily to
Caucasians.
For example, in Chapter 4, "The Human Genome Project and the
African American Community: Race, Diversity, and American
Science," noted University of Maryland scholar Fatima Jackson sheds
some light on the unstated proposal. Those familiar with a famous 1990
case from the California Supreme Court will be familiar with the
context of Henrietta Lacks' story. The California legal system allowed
the University of California to benefit financially from the
unconsented-to use of spleen cells taken from cancer patient John
Moore. The University of California was not required to share any
financial bounties with Mr. Moore. Likewise, Ms. Lacks, an AfricanAmerican resident of Maryland, never received financial compensation,
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or credit, for the scientific and medical benefits that resulted when her
cells were used without her consent by Johns Hopkins University. When
Ms. Lacks was a patient at Johns Hopkins in 1951, doctors took her
cells and used them as the basis for the extremely valuable HeLa cell
typing system. Jackson purports that there has not been financial
compensation or credit for this important scientific contribution.
Lastly, the editors report failure in their effort to promote
interaction between scientists who perform HGP research and leaders
of the minority community. The editors write of their disappointment,
or perhaps surprise, that while administrators and managers at leading
research institutions promised to encourage working scientists to
participate in the conference, none of the bench scientists participated as
the editors desired. The scientists doing cutting-edge genetics research
were willing to address the conference, but not to participate as resource
persons.
Nonetheless, Zilinskas and Balint remain optimistic and argue that
the HGP has the potential to make dramatic positive contributions to
the health of all human beings. They stress that members of minority
communities have much to gain from innovative medical diagnostics
and therapies that will result from the study of human genetics. This
book, they hope, will serve as both the media and the message for the
important task of bridging the gap between the scientific and minority
communities.

Craig Steven Jepsont
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Mr. Jepson is a Professor of Law at the Franklin Pierce Law Center, Of Counsel with
Verrill & Dana LLP, Portland, Maine, and a consultant to the Food Research and
Development Institute of the government of Taiwan. Mr. Jepson teaches Biotechnology Law at
FPLC and the University of Maine.
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Join the Risk Assessment & Policy Association
On the web, see http://www.fplc.edu/risk/rapa.htm.

The March 2001 Biennial International Conference
has been postponed until 2002.
Future Biennial International Conferences will be on
a schedule for even-numbered years.
In the interim, the RAPA officers are exploring the possibility
of sponsoring a one-day symposium in Washington, D.C. later
this year (with the possibility of sponsoring similar symposiums
on a biennial schedule of odd-numbered years).

